Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris

British Journal of Dermatology

Volumn 162, Issue 2, 2010, Pages 296-303

  Caillon, F ^a,b   O'Connell, M ^b   Eady, E A ^b   Jenkins, G R ^c   Cove, J H ^a   Layton, A M ^b   Mountford, A P ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Acne; CD14; Interleukin 10

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CELL CULTURE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN FUNCTION; VENOUS BLOOD;

ACNE VULGARIS; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE; PROPIONIBACTERIUM ACNES; STATISTICS AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 74349095834     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09420.x     Document Type: Article

References (36)

1. Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol 1997 38 : 115 123.
2. Eady EA, Cove JH. Is acne an infection of blocked pilosebaceous follicles? Implications for antimicrobial treatment. Am J Clin Dermatol 2000 1 : 201 209.
3. Jeremy AH, Holland DB, Roberts SG et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003 121 : 20 7.
4. Ingham E, Eady EA, Goodwin CE et al. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992 98 : 895 901.
5. Kim J, Ochoa MT, Krutzik SR et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002 169 : 1535 1541.
6. Sugisaki H, Yamanaka K, Kakeda M et al. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci 2009 55 : 47 52.
7. Schaller M, Loewenstein M, Borelli C et al. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br J Dermatol 2005 153 : 66 71.
8. Ma J, Chen T, Mandelin J et al. Regulation of macrophage activation. Cell Mol Life Sci 2003 60 : 2334 2346.
9. Moore KW, de Waal Malefyt R, Coffman RL et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001 19 : 683 765.
10. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003 3 : 133 146.
11. Weiss E, Mamelak AJ, La Morgia S et al. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases. J Am Acad Dermatol 2004 50 : 657 675.
12. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005 6 : 353 360.
13. Birch KE, Vukmanovic-Stejic M, Reed JR et al. The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin. Br J Dermatol 2005 152 : 409 417.
14. Suh DH, Kwon TE, Youn JI. Changes of comedonal cytokines and sebum secretion after UV irradiation in acne patients. Eur J Dermatol 2002 12 : 139 144.
15. Kang S, Cho S, Chung JH et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 2005 166 : 1691 1699.
16. Burke BM, Cunliffe WJ. The assessment of acne vulgaris - the Leeds technique. Br J Dermatol 1984 111 : 83 92.
17. Basal E, Jain A, Kaushal GP. Antibody response to crude cell lysate of Propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects. J Microbiol 2004 42 : 117 125.
18. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995 63 : 3158 3165.
19. Liu PT, Phan J, Tang D et al. CD209(+) macrophages mediate host defense against Propionibacterium acnes. J Immunol 2008 180 : 4919 4923.
20. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008 180 : 5771 5777.
21. + T-cell responses to Propionibacterium acnes. Br J Dermatol 2007 156 : 460 465.
22. Dudda JC, Perdue N, Bachtanian E et al. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med 2008 205 : 1559 1565.
23. Keller CC, Yamo O, Ouma C et al. Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia. Infect Immun 2006 74 : 5249 5260.
24. Jugeau S, Tenaud I, Knol AC et al. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol 2005 153 : 1105 1113.
25. Reuss E, Fimmers R, Kruger A et al. Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study. Genes Immun 2002 3 : 407 413.
26. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics 1996 45 : 82 3.
27. Hensen P, Asadullah K, Windemuth C et al. Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis. Br J Dermatol 2003 149 : 381 385.
28. Kingo K, Koks S, Silm H et al. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun 2003 4 : 455 457.
29. Stewart ME, Downing DT, Cook JS et al. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol 1992 128 : 1345 1348.
30. Tabata N, Tagami H, Terui T. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch Dermatol Res 1997 289 : 410 414.
31. Suzuki T, Suzuki N, Engleman EG et al. Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1995 99 : 251 255.
32. Werfel T, Wittmann M. Regulatory role of T lymphocytes in atopic dermatitis. Chem Immunol Allergy 2008 94 : 101 111.
33. Kuhn A, Beissert S, Krammer PH. CD4(+)CD25(+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res 2009 301 : 71 81.
34. Teige I, Hvid H, Svensson L et al. Regulatory T cells control VEGF-dependent skin inflammation. J Invest Dermatol 2009 129 : 1437 1445.
35. Friedrich M, Docke WD, Klein A et al. Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in psoriasis. J Invest Dermatol 2002 118 : 672 677.
36. Lingnau M, Hoflich C, Volk HD et al. Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes. Hum Immunol 2007 68 : 730 738.